FOXO3 and cancer: Importantly, several clinical studies on the relationship between the FOXO3 protein nuclear localization or expression level and cancer patient survival rates have revealed that FOXO3 is a good prognostic biomarker for cancer survival (12,32–34), which suggests that the regulation of FOXO3 activation in cancer cells may be a promising strategy for developing anticancer therapeutic drugs.